Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 12, 2020

SELL
$13.02 - $20.31 $139,092 - $216,971
-10,683 Closed
0 $0
Q4 2019

Jan 29, 2020

BUY
$16.88 - $20.83 $1,823 - $2,249
108 Added 1.02%
10,683 $211,000
Q3 2019

Nov 15, 2019

SELL
$16.15 - $17.99 $1,598 - $1,781
-99 Reduced 0.93%
10,575 $182,000
Q2 2019

Jul 26, 2019

BUY
$16.58 - $20.49 $176,974 - $218,710
10,674 New
10,674 $189,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.